The Clinical Challenges of AAV Vectors

Kanmin Xue, PhD, MA, MB, BChir, FRCOphth

Show Description +

Dr. Xue examines the immunological reactions to AAV vectors and what it means for the advancement of gene therapies.

Posted: 10/03/2024

Keywords:

retina-meeting-recap

•

immunology

•

adreno-associated virus, AAV

•

Gene Therapy

Up Next

Name: The Clinical Challenges of AAV Vectors
Uploaded: 2024-10-03T19:54:50+00:00
Description: Dr. Xue examines the immunological reactions to AAV vectors and what it means for the advancement of gene therapies.

Plasma Kallikrein Inhibition: A Novel Approach to DME

Arshad Khanani, MD, MA, FASRS

Next-Gen Therapies for AMD and DME

Nicole Eter, MD

The Role of Anti-VEGF Therapy in Diabetic Vitreous Hemorrhage

David Steel, MD, MBBS, FRCOphth

Exploring VEGF-C and -D Inhibition

Timothy L. Jackson, PhD, MB ChB, FRCOphth

The Clinical Benefits of the PDS

Patricia Udaondo, MD

RD Repair: Why Slower Reattachment is Better

Stratos V. Gotzaridis, MBBS, MD

Today's Approaches to Myopic Neovascularization

Gemmy Cheung, MBBS, FRCOphth, FAMS, MCI

Anti-VEGF for ROP: Efficacy and Safety Outcomes

Andreas Stahl, MD

Advancing Research Methodology in Retina

Varun Chaudhary, MD, FRCS(C)

Back to All Videos

The Clinical Challenges of AAV Vectors

Kanmin Xue, PhD, MA, MB, BChir, FRCOphth

Dr. Xue examines the immunological reactions to AAV vectors and what it means for the advancement of gene therapies.

Posted: 10/03/2024

Keywords:

retina-meeting-recap

•

immunology

•

adreno-associated virus, AAV

•

Gene Therapy

Please log in to leave a comment.

Meeting Coverage:

EURETINA Congress

The Clinical Challenges of AAV Vectors

Up Next

The Clinical Challenges of AAV Vectors

More From EURETINA: 2024 Coverage